These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7543818)

  • 21. Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis.
    Zania P; Gourni D; Aplin AC; Nicosia RF; Flordellis CS; Maragoudakis ME; Tsopanoglou NE
    J Pharmacol Exp Ther; 2009 Feb; 328(2):378-89. PubMed ID: 18988770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a potent peptide antagonist to an active laminin-1 sequence that blocks angiogenesis and tumor growth.
    Ponce ML; Hibino S; Lebioda AM; Mochizuki M; Nomizu M; Kleinman HK
    Cancer Res; 2003 Aug; 63(16):5060-4. PubMed ID: 12941835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
    Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
    Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laminin peptides stimulate human neutrophil motility.
    Harvath L; Brownson NE; Fields GB; Skubitz AP
    J Immunol; 1994 Jun; 152(11):5447-56. PubMed ID: 8189064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy.
    Hibino S; Shibuya M; Engbring JA; Mochizuki M; Nomizu M; Kleinman HK
    Cancer Res; 2004 Jul; 64(14):4810-6. PubMed ID: 15256450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases.
    Gualandris A; Rusnati M; Belleri M; Nelli EE; Bastaki M; Molinari-Tosatti MP; Bonardi F; Parolini S; Albini A; Morbidelli L; Ziche M; Corallini A; Possati L; Vacca A; Ribatti D; Presta M
    Cell Growth Differ; 1996 Feb; 7(2):147-60. PubMed ID: 8822198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of antiangiogenin peptide using a phage-displayed peptide library.
    Gho YS; Lee JE; Oh KS; Bae DG; Chae CB
    Cancer Res; 1997 Sep; 57(17):3733-40. PubMed ID: 9288781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2.
    Sakamoto N; Iwahana M; Tanaka NG; Osada Y
    Cancer Res; 1991 Feb; 51(3):903-6. PubMed ID: 1703042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of laminin-5 in TGF alpha/EGF-mediated corneal epithelial cell motility.
    Qin P; Kurpakus MA
    Exp Eye Res; 1998 May; 66(5):569-79. PubMed ID: 9628804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo.
    Xiao D; Singh SV
    Cancer Res; 2007 Mar; 67(5):2239-46. PubMed ID: 17332354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro.
    Bootle-Wilbraham CA; Tazzyman S; Marshall JM; Lewis CE
    Cancer Res; 2000 Sep; 60(17):4719-24. PubMed ID: 10987275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of angiogenesis by a novel small peptide consisting of the active fragments of platelet factor-4 and vasostatin.
    Li X; Jiang L; Wang Y; Xiao Y; Huang Y; Yao Q; Yang Y; Wu X
    Cancer Lett; 2007 Oct; 256(1):29-32. PubMed ID: 17574330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-beta 1 in vitro.
    Stolz DB; Michalopoulos GK
    J Cell Physiol; 1997 Jan; 170(1):57-68. PubMed ID: 9012785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth.
    He GA; Luo JX; Zhang TY; Wang FY; Li RF
    Biochem Biophys Res Commun; 2003 Dec; 312(3):801-5. PubMed ID: 14680836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature.
    Sills AK; Williams JI; Tyler BM; Epstein DS; Sipos EP; Davis JD; McLane MP; Pitchford S; Cheshire K; Gannon FH; Kinney WA; Chao TL; Donowitz M; Laterra J; Zasloff M; Brem H
    Cancer Res; 1998 Jul; 58(13):2784-92. PubMed ID: 9661892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laminin responsiveness is associated with changes in fibroblast morphology, motility, and anchorage-independent growth: cell system for examining the interaction between laminin and EGF signaling pathways.
    Lin ML; Bertics PJ
    J Cell Physiol; 1995 Sep; 164(3):593-604. PubMed ID: 7650067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices.
    Sanz L; Kristensen P; Blanco B; Facteau S; Russell SJ; Winter G; Alvarez-Vallina L
    Gene Ther; 2002 Aug; 9(15):1049-53. PubMed ID: 12101437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.